BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20403617)

  • 1. Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate.
    McCullough AR; Hellstrom WG; Wang R; Lepor H; Wagner KR; Engel JD
    J Urol; 2010 Jun; 183(6):2451-6. PubMed ID: 20403617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. A. R. McCullough, W. G. Hellstrom, R. Wang, H. Lepor, K. R. Wagner and J. D. Engel. J Urol 2010; 183: 2451-2456.
    Levinson AW
    J Urol; 2011 Apr; 185(4):1540-1; author reply 1540-1. PubMed ID: 21345457
    [No Abstract]   [Full Text] [Related]  

  • 3. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
    Pavlovich CP; Levinson AW; Su LM; Mettee LZ; Feng Z; Bivalacqua TJ; Trock BJ
    BJU Int; 2013 Oct; 112(6):844-51. PubMed ID: 23937708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil.
    Bannowsky A; Schulze H; van der Horst C; Hautmann S; Jünemann KP
    BJU Int; 2008 May; 101(10):1279-83. PubMed ID: 18284406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil.
    Mevcha A; Gulur DM; Persad R; Gillatt D
    BJU Int; 2009 May; 103(10):1440; author reply 1440-1. PubMed ID: 19453551
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of intraurethral alprostadil in patients not responding to sildenafil citrate.
    Jaffe JS; Antell MR; Greenstein M; Ginsberg PC; Mydlo JH; Harkaway RC
    Urology; 2004 May; 63(5):951-4. PubMed ID: 15134987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy.
    Nehra A; Blute ML; Barrett DM; Moreland RB
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S38-42. PubMed ID: 11850734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy: medicated urethral system for erection enhances sexual satisfaction in sildenafil citrate failure following nerve-sparing radical prostatectomy.
    Raina R; Nandipati KC; Agarwal A; Mansour D; Kaelber DC; Zippe CD
    J Androl; 2005; 26(6):757-60. PubMed ID: 16291971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy.
    Mydlo JH; Viterbo R; Crispen P
    BJU Int; 2005 Apr; 95(6):843-6. PubMed ID: 15794795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial.
    Scholz M; Strum S
    J Urol; 1999 Jun; 161(6):1914-5. PubMed ID: 10332471
    [No Abstract]   [Full Text] [Related]  

  • 11. Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management.
    Nandipati KC; Raina R; Agarwal A; Zippe CD
    Drugs Aging; 2006; 23(2):101-17. PubMed ID: 16536634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nerve-sparing radical prostatectomy with nightly low-dose sildenafil : rehabilitation of erectile function].
    Bannowsky A; Schulze H; van der Horst C; Jünemann KP
    Urologe A; 2010 Dec; 49(12):1516-21. PubMed ID: 21107805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing and managing erectile dysfunction after prostatectomy for prostate cancer.
    Albaugh JA
    Urol Nurs; 2010; 30(3):167-177, 166. PubMed ID: 20648854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial.
    Montorsi F; Guazzoni G; Strambi LF; Da Pozzo LF; Nava L; Barbieri L; Rigatti P; Pizzini G; Miani A
    J Urol; 1997 Oct; 158(4):1408-10. PubMed ID: 9302132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraurethral alprostadil for erectile dysfunction: a review of the literature.
    Costa P; Potempa AJ
    Drugs; 2012 Dec; 72(17):2243-54. PubMed ID: 23170913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy.
    Gontero P; Fontana F; Zitella A; Montorsi F; Frea B
    BJU Int; 2005 Feb; 95(3):359-65. PubMed ID: 15679794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erectile dysfunction following nerve-sparing radical retropubic prostatectomy and its treatment with sildenafil.
    Shimizu T; Hisasue S; Sato Y; Kato R; Kobayashi K; Tsukamoto T
    Int J Urol; 2005 Jun; 12(6):552-7. PubMed ID: 15985077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early versus late rehabilitation of erectile function after nerve-sparing radical cystoprostatectomy: a prospective randomized study.
    Mosbah A; El Bahnasawy M; Osman Y; Hekal IA; Abou-Beih E; Shaaban A
    J Sex Med; 2011 Jul; 8(7):2106-11. PubMed ID: 20946162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil citrate after radical retropubic prostatectomy.
    Lowentritt BH; Scardino PT; Miles BJ; Orejuela FJ; Schatte EC; Slawin KM; Elliott SP; Kim ED
    J Urol; 1999 Nov; 162(5):1614-7. PubMed ID: 10524880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence.
    Mathers MJ; Klotz T; Brandt AS; Roth S; Sommer F
    BJU Int; 2008 May; 101(9):1129-34. PubMed ID: 18190629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.